Dolf de Meijer

Dolf de Meijer has extensive experience in regulatory affairs and clinical research, currently serving as Associate Director of CMC Regulatory Affairs at Merus N.V. since May 2019, following roles as Sr. Manager and Regulatory Affairs CMC Associate. Prior to Merus, Dolf worked at Sanquin Plasma Products B.V. from February 2011 to April 2019 as Sr. Regulatory Affairs Officer and Regulatory Affairs Officer. Dolf's career began at Roche Pharmaceuticals as a Clinical Research Associate from August 2009 to January 2011, and at PPD as a Research Assistant from March 2008 to July 2009. Academic qualifications include an MSc in Biomedical Sciences, specializing in the Biology of Disease, and a Master's profile in Drug Regulatory Sciences, both obtained from Utrecht University, complemented by a high school diploma from Christelijk Lyceum Veenendaal.